ME01834B - Farmaceutska kompozicija ibuprofena za injekciju - Google Patents
Farmaceutska kompozicija ibuprofena za injekcijuInfo
- Publication number
- ME01834B ME01834B MEP-2014-74A MEP7414A ME01834B ME 01834 B ME01834 B ME 01834B ME P7414 A MEP7414 A ME P7414A ME 01834 B ME01834 B ME 01834B
- Authority
- ME
- Montenegro
- Prior art keywords
- pharmaceutical composition
- ibuprofen
- injection
- composition
- concentration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Claims (15)
1.Farmaceutska kompozicija ibuprofena za injekciju koja sadrži vodeni rastvor ibuprofena i trometamola, pri čemu je koncentracija ibuprofena između 2 i 6 mg/ml, dok je koncentracija trometamola između 1,8 i 5,8 mg/ml, i pH je između 7,0 i 9,5.
2.Farmaceutska kompozicija ibuprofena za injekciju prema zahtJevu 1, pri čemu je koncentracija ibuprofena oko 4 mg/ml.
3.Farmaceutska kompozicija prema zahtjevima 1 ili 2, pri čemu je koncentracija trometamola približno 3,8 mg/ml.
4.Farmaceutska kompozicija prema bilo kom od prethodnih zahtjeva 1 do 3 koja se može sterilizovati toplotom autoklaviranjem na temperaturi između 1100°C i 130°C tokom vremenskog perioda između 2 i 190 minuta.
5.Farmaceutska kompozicija prema zahtjevu 4, pri čemu se kompozicija može sterilizovati toplotom autoklaviranjem na temperaturi od 121°C tokom 15 minuta.
6.Farmaceutska .kompozicija ibuprofena za injekciju prema bilo kom od prethodnih zahtjeva 1 do 5, pri čemu, kada je kompozicija stavljena u kontejnere od stakla, onda je pH između 7,0 i 9,5.
7.Farmaceutska kompozicija ibuprofena za injekciju prema bilo kom od prethodnih zahtjeva 1 do 5, pri čemu, kada je kompozicija stavljena u kontejnere od polietilena, onda je pH između 7,0 i 9,0.
8.Farmaceutska kompozicija ibuprofena za injekciju prema bilo kom od prethodnih zahtjeva 1 do 5, pri čemu, kada je kompozicija stavljena u kontejnere od polipropilena, onda je pH između 7,5 i 9,0.
9.Farmaceutska kompozicija ibuprofena za injekciju prema bilo kom od prethodnih zahtjeva 1 do 5, pri čemu, kada je kompozicija stavljena u kontejnere od PVC-a, onda je pH između 8,0 i 9,0.
10.Farmaceutska kompozicija prema bilo kom od prethodnih zahtjeva, pri čemu je pH oko 8,5.
11.Farmaceutska kompozicija prema bilo kom od prethodnih zahtjeva, koja dalje sadrži so u količini koja je neophodna da kompozicija dobije osmolalnost od oko 300 mOsm/kg.
12. Farmaceutska kompozicija prema zahtjevu 11, pri čemu je so NaCl u koncentraciji od približno 7,7 mg/ml.
13. Kompozicija prema bilo kom od zahtjeva 1 do 12 za primenu u liječenju bola, zapaljenja ili groznice.
14. Kompozicija prema zahtjevu 13, koja je stavljena u kontejnere od 1OO ml ili 200 ml.
15. Primena farmaceutske kompozicije prema bilo kom od zahtjeva 1 do 12 za dobijanje leka za liječenje bola, zapaljenja ili groznice.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/ES2010/070330 WO2011144766A1 (es) | 2010-05-18 | 2010-05-18 | Composición farmacéutica de ibuprofeno para inyección |
| EP11720479.2A EP2571488B2 (en) | 2010-05-18 | 2011-05-18 | Pharmaceutical composition of ibuprofen for injection |
| PCT/EP2011/058087 WO2011144677A1 (en) | 2010-05-18 | 2011-05-18 | Pharmaceutical composition of ibuprofen for injection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ME01834B true ME01834B (me) | 2014-12-20 |
Family
ID=43589415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2014-74A ME01834B (me) | 2010-05-18 | 2011-05-18 | Farmaceutska kompozicija ibuprofena za injekciju |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US9114165B2 (me) |
| EP (1) | EP2571488B2 (me) |
| JP (1) | JP6018048B2 (me) |
| KR (1) | KR101770808B1 (me) |
| CN (1) | CN102892410B (me) |
| AU (1) | AU2011254583B2 (me) |
| BR (1) | BR112012029171B1 (me) |
| CA (1) | CA2798575C (me) |
| CL (1) | CL2012003119A1 (me) |
| CO (1) | CO6650419A2 (me) |
| CR (1) | CR20120559A (me) |
| CY (1) | CY1115394T1 (me) |
| DK (1) | DK2571488T4 (me) |
| EC (1) | ECSP12012274A (me) |
| ES (1) | ES2478491T5 (me) |
| HR (1) | HRP20140622T4 (me) |
| IL (1) | IL222497A0 (me) |
| MA (1) | MA34176B1 (me) |
| ME (1) | ME01834B (me) |
| MX (1) | MX2012013402A (me) |
| MY (1) | MY160302A (me) |
| NZ (1) | NZ602957A (me) |
| PE (1) | PE20130374A1 (me) |
| PH (1) | PH12012502274A1 (me) |
| PL (1) | PL2571488T5 (me) |
| PT (1) | PT2571488E (me) |
| RS (1) | RS53408B2 (me) |
| RU (1) | RU2012154628A (me) |
| SG (1) | SG185061A1 (me) |
| SI (1) | SI2571488T2 (me) |
| SM (1) | SMT201400103B (me) |
| TN (1) | TN2012000487A1 (me) |
| UA (1) | UA103290C2 (me) |
| WO (2) | WO2011144766A1 (me) |
| ZA (1) | ZA201207948B (me) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9072710B2 (en) * | 2012-03-16 | 2015-07-07 | Cumberland Pharmaceuticals Inc. | Injectable ibuprofen formulation |
| CN104323988A (zh) * | 2014-11-27 | 2015-02-04 | 北京蓝丹医药科技有限公司 | 一种用于注射的右旋布洛芬药物组合物 |
| CN105055389B (zh) * | 2015-08-03 | 2018-08-10 | 北京蓝丹医药科技有限公司 | 一种用于早产儿先天性心脏病的布洛芬药物组合物 |
| CN105997901A (zh) * | 2016-07-27 | 2016-10-12 | 济南东方开元医药新技术有限公司 | 小儿注射用布洛芬氨丁三醇冻干粉针组合物及制备方法 |
| WO2020120756A1 (en) * | 2018-12-14 | 2020-06-18 | Fresenius Kabi Austria Gmbh | Pharmaceutical compositions for parenteral administration comprising ibuprofen and a phosphate buffer |
| CN112526013B (zh) * | 2020-11-20 | 2022-09-06 | 人福普克药业（武汉）有限公司 | 超高液相色谱法检测布洛芬药物中有关物质浓度方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19912436A1 (de) * | 1999-03-19 | 2000-09-21 | Merckle Gmbh | Ibuprofen-Lösung |
| US20040132823A1 (en) | 2001-11-02 | 2004-07-08 | Leo Pavliv | Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
| JP5185488B2 (ja) | 2001-11-02 | 2013-04-17 | カンバーランド ファーマシューティカルズ，インコーポレーテッド | ２−（４−イソブチルフェニル）プロピオン酸の医薬組成物 |
| ITMI20040235A1 (it) | 2004-02-13 | 2004-05-13 | Therapicon Srl | Preparazione farmaceutica per il cavo orale |
-
2010
- 2010-05-18 WO PCT/ES2010/070330 patent/WO2011144766A1/es not_active Ceased
-
2011
- 2011-05-18 BR BR112012029171-8A patent/BR112012029171B1/pt active IP Right Grant
- 2011-05-18 PT PT11720479T patent/PT2571488E/pt unknown
- 2011-05-18 US US13/641,921 patent/US9114165B2/en active Active
- 2011-05-18 RS RS20140366A patent/RS53408B2/sr unknown
- 2011-05-18 HR HRP20140622TT patent/HRP20140622T4/hr unknown
- 2011-05-18 EP EP11720479.2A patent/EP2571488B2/en active Active
- 2011-05-18 ES ES11720479.2T patent/ES2478491T5/es active Active
- 2011-05-18 SI SI201130206T patent/SI2571488T2/sl unknown
- 2011-05-18 CN CN201180024380.7A patent/CN102892410B/zh not_active Ceased
- 2011-05-18 NZ NZ60295711A patent/NZ602957A/en unknown
- 2011-05-18 AU AU2011254583A patent/AU2011254583B2/en active Active
- 2011-05-18 PH PH1/2012/502274A patent/PH12012502274A1/en unknown
- 2011-05-18 MX MX2012013402A patent/MX2012013402A/es active IP Right Grant
- 2011-05-18 MY MYPI2012700890A patent/MY160302A/en unknown
- 2011-05-18 RU RU2012154628/15A patent/RU2012154628A/ru unknown
- 2011-05-18 DK DK11720479.2T patent/DK2571488T4/en active
- 2011-05-18 ME MEP-2014-74A patent/ME01834B/me unknown
- 2011-05-18 SG SG2012079570A patent/SG185061A1/en unknown
- 2011-05-18 MA MA35330A patent/MA34176B1/fr unknown
- 2011-05-18 PE PE2012002182A patent/PE20130374A1/es not_active Application Discontinuation
- 2011-05-18 JP JP2013510623A patent/JP6018048B2/ja active Active
- 2011-05-18 CA CA2798575A patent/CA2798575C/en active Active
- 2011-05-18 PL PL11720479T patent/PL2571488T5/pl unknown
- 2011-05-18 WO PCT/EP2011/058087 patent/WO2011144677A1/en not_active Ceased
- 2011-05-18 KR KR1020127032850A patent/KR101770808B1/ko active Active
- 2011-05-18 UA UAA201214485A patent/UA103290C2/ru unknown
-
2012
- 2012-10-09 TN TNP2012000487A patent/TN2012000487A1/en unknown
- 2012-10-17 IL IL222497A patent/IL222497A0/en unknown
- 2012-10-17 EC ECSP12012274 patent/ECSP12012274A/es unknown
- 2012-10-22 ZA ZA2012/07948A patent/ZA201207948B/en unknown
- 2012-11-01 CR CR20120559A patent/CR20120559A/es unknown
- 2012-11-07 CL CL2012003119A patent/CL2012003119A1/es unknown
- 2012-12-17 CO CO12228358A patent/CO6650419A2/es unknown
-
2014
- 2014-07-29 SM SM201400103T patent/SMT201400103B/xx unknown
- 2014-07-30 CY CY20141100574T patent/CY1115394T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ME01834B (me) | Farmaceutska kompozicija ibuprofena za injekciju | |
| HRP20210980T1 (hr) | Stabilna bez konzervansa midrijatska i protuupalna otopina za injekciju | |
| SI2648520T1 (en) | Dexmedetomidine premix formulation | |
| BR112014008551A2 (pt) | conjunto de válvulas para uso com recipiente de líquido e frasco de medicamento | |
| HRP20171939T1 (hr) | Formulacija protutijela i režimi terapije | |
| HRP20201948T1 (hr) | Pripravci inhibitora dopa-dekarbokilaze | |
| HRP20211520T1 (hr) | Postupci i pripravci za dostavu iduronat-2-sulfataze u središnji živčani sustav | |
| HRP20161311T1 (hr) | Tekući farmaceutski pripravak | |
| BR112014028600A8 (pt) | Formulações de suspensão compreendendo anticorpo monoclonal de alta concentração, seu método de preparação, seu uso e dispositivo para sua administração subcutânea, e método para produção de um artigo de fabricação | |
| ES2963823T3 (es) | Sistema para dosificar líquidos | |
| HRP20180237T4 (hr) | Metode za liječenje hcv-a | |
| HRP20180514T1 (hr) | Kontinuirana primjena l-dopa, inhibitora dopa dekarboksilaze, inhibitora katekol-o-metiltransferaze i sastava za isto | |
| RU2011121612A (ru) | Инъекционная композиция полидезоксирибонуклеотидов для лечения костно-суставных заболеваний | |
| MY162175A (en) | Aqueous drug delivery system | |
| BR112013032217A2 (pt) | "anticorpo anti-nkg2a, ou fragmento de ligação de antígeno do mesmo, seu usos, e formulação farmacêutica". | |
| PE20081578A1 (es) | Formulacion en polvo de valganciclovir | |
| FI3528787T3 (fi) | Farmaseuttisia formulaatioita ja menetelmiä niiden valmistamiseksi | |
| RU2015119603A (ru) | Стабильная фармацевтическая композиция на основе слитого белка tnfr:fc | |
| CN104824050A (zh) | 一种耐腐蚀型医疗器械消毒液 | |
| CY1113683T1 (el) | Συστημα συσκευασιας για φαρμακευτικες συνθεσεις και kit για ενδοφλεβια χορηγηση | |
| GT200900236A (es) | Sales de adición de ácido, hidratos y polimorfos de la etil-amida del ácido 5-(2,4-dihidroxi-5-isopopril-fenil)-4-(4-morfolin-4-il-metil-fenil)-isoxazol-3-carboxílico, y formulaciones que comprenden esta formas.- | |
| BR112014030615A2 (pt) | recipiente de múltiplos compartimentos para líquidos biológicos | |
| ES2343777B1 (es) | Procedimiento de recogida y envasado farmaceutico de agua de mar. | |
| CN102068405A (zh) | 一种酮洛芬凝胶及其制备方法 | |
| RU2014148062A (ru) | Инъекционная фармацевтическая композиция декскетопрофена и трамадола |